---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-017888"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2021-07-29T23:59:59+00:00"
generated_at: "2026-06-30T00:47:15.122146+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Q2 2021 sales $40.7M (+64% YoY), EPS $0.40; declares $0.11 dividend; FY21 guidance raised

## Summary
- Sales $40.7M (+64% or +35% organic); operating income $11.1M (+128%); net income $8.3M (+137%); diluted EPS $0.40 (+131%).
- Gross margin 65.8% vs 68.5% in Q2 2020; decline driven by product mix, manufacturing inefficiencies, and inventory write-downs.
- Quarterly dividend of $0.11/share approved, payable Sept 9, 2021 to record holders on Aug 26, 2021.
- FY 2021 guidance: sales $154.1M–$158.1M (+21% YoY at midpoint), EPS $1.30–$1.40 (+30% at midpoint).
- Completed $54.5M follow-on stock offering on July 16; $23.0M net proceeds used to repay long-term debt.

## SEC filing metadata
- accession: 0001437749-21-017888
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2021-07-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000143774921017888/0001437749-21-017888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000143774921017888/lmat20210729_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-017888
- JSON: https://secwatch.observer/filing/0001437749-21-017888.json
- Plain text: https://secwatch.observer/filing/0001437749-21-017888.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.